MAGEA4 c.946G>C ;(p.G316R)

Variant ID: X-151093082-G-C

NM_001011548.1(MAGEA4):c.946G>C;(p.G316R)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Jang, H Josh HJ; Hostetter, Galen G; MacFarlane, Alexander W AW; Madaj, Zachary Z; Ross, Eric A EA; Hinoue, Toshinori T; Kulchycki, Justin R JR; Burgos, Ryan S RS; Tafseer, Mahvish M; Alpaugh, R Katherine RK; Schwebel, Candice L CL; Kokate, Rutika R; Geynisman, Daniel M DM; Zibelman, Matthew R MR; Ghatalia, Pooja P; Nichols, Peter W PW; Chung, Woonbok W; Madzo, Jozef J; Hahn, Noah M NM; Quinn, David I DI; Issa, Jean-Pierre J JJ; Topper, Michael J MJ; Baylin, Stephen B SB; Shen, Hui H; Campbell, Kerry S KS; Jones, Peter A PA; Plimack, Elizabeth R ER
Publication Date: 2023-03-16

Variant appearance in text: MAGEA4: G316R
PubMed Link: 36928921
Variant Present in the following documents:
  • ccr-22-3642_supplementary_tables_1_suppts1.xlsx, sheet 3
View BVdb publication page



SMAP is a pipeline for sample matching in proteogenomics.

Nature Communications
Li, Ling L; Niu, Mingming M; Erickson, Alyssa A; Luo, Jie J; Rowbotham, Kincaid K; Guo, Kai K; Huang, He H; Li, Yuxin Y; Jiang, Yi Y; Hur, Junguk J; Liu, Chunyu C; Peng, Junmin J; Wang, Xusheng X
Publication Date: 2022-02-08

Variant appearance in text: MAGEA4: G316R
PubMed Link: 35136070
Variant Present in the following documents:
  • 41467_2022_28411_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



Consequences of point mutations in melanoma-associated antigen 4 (MAGE-A4) protein: Insights from structural and biophysical studies.

Scientific Reports
Hagiwara, Yoshio Y; Sieverling, Lina L; Hanif, Farina F; Anton, Jensy J; Dickinson, Eleanor R ER; Bui, Tam T T TT; Andreeva, Antonina A; Barran, Perdita E PE; Cota, Ernesto E; Nikolova, Penka V PV
Publication Date: 2016-04-28

Variant appearance in text: MAGE4: G316R
PubMed Link: 27121989
Variant Present in the following documents:
  • Main text
  • srep25182.pdf
View BVdb publication page



Integrated analysis of germline and somatic variants in ovarian cancer.

Nature Communications
Kanchi, Krishna L KL; Johnson, Kimberly J KJ; Lu, Charles C; McLellan, Michael D MD; Leiserson, Mark D M MD; Wendl, Michael C MC; Zhang, Qunyuan Q; Koboldt, Daniel C DC; Xie, Mingchao M; Kandoth, Cyriac C; McMichael, Joshua F JF; Wyczalkowski, Matthew A MA; Larson, David E DE; Schmidt, Heather K HK; Miller, Christopher A CA; Fulton, Robert S RS; Spellman, Paul T PT; Mardis, Elaine R ER; Druley, Todd E TE; Graubert, Timothy A TA; Goodfellow, Paul J PJ; Raphael, Benjamin J BJ; Wilson, Richard K RK; Ding, Li L
Publication Date: 2014

Variant appearance in text: MAGEA4: G316R
PubMed Link: 24448499
Variant Present in the following documents:
  • NIHMS551112-supplement-9.xlsx, sheet 1
View BVdb publication page



Frequent MAGE mutations in human melanoma.

Plos One
Caballero, Otavia L OL; Zhao, Qi Q; Rimoldi, Donata D; Stevenson, Brian J BJ; Svobodová, Suzanne S; Devalle, Sylvie S; Röhrig, Ute F UF; Pagotto, Anna A; Michielin, Olivier O; Speiser, Daniel D; Wolchok, Jedd D JD; Liu, Cailian C; Pejovic, Tanja T; Odunsi, Kunle K; Brasseur, Francis F; Van den Eynde, Benoit J BJ; Old, Lloyd J LJ; Lu, Xin X; Cebon, Jonathan J; Strausberg, Robert L RL; Simpson, Andrew J AJ
Publication Date: 2010-09-16

Variant appearance in text: MAGEA4: G316R
PubMed Link: 20862285
Variant Present in the following documents:
  • Main text
  • pone.0012773.pdf
View BVdb publication page